Recent studies have shown that granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF), a major driver of MDSCs recruitment and differentiation, is abundant in the lungs of COVID-19 patients. This evidence concerns the gene CSF3 and COVID-19.